← Eichor
Study identifier: NCT03699956 Synced from ClinicalTrials.gov · July 28, 2026
● Terminated

RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer

Condition: Carcinoma, Small Cell Lung  ·  Sponsor: EpicentRx, Inc.

PhasePhase 3
Planned participants18
Who can joinAll sexes, 18 Years to 79 Years
Healthy volunteersNo

About this study

This Phase 3 study aims to find out whether RRx-001 + platinum chemotherapy is more effective than platinum chemotherapy alone in 3rd line or beyond small cell cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (18)

Centura Health Research CenterDenver, Colorado, United States
Mid Florida Hematology and Oncology CenterOrange City, Florida, United States
AdventHealth Hematology and OncologyOrlando, Florida, United States
H. Lee Moffitt Cancer Center & Research Institute, Inc.Tampa, Florida, United States
Rush University Medical CenterChicago, Illinois, United States
Cotton O'Neil Clinical Research Center.Hematology & OncologyTopeka, Kansas, United States
The University of Kansas Cancer CenterWestwood, Kansas, United States
Norton Cancer Institute, Norton Healthcare PavilionLouisville, Kentucky, United States
University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer CenterBaltimore, Maryland, United States
University of Mississippi Medical CenterJackson, Mississippi, United States
Washington University School of Medicine - Siteman Cancer CenterSt Louis, Missouri, United States
Oncology Hematology West PC dba Nebraska Cancer SpecialistsOmaha, Nebraska, United States

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03699956